ECM
SONM icon

ExodusPoint Capital Management’s DNA X Inc SONM Stock Holding History

ExodusPoint Capital Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6
Closed -$9K – 2191
2020
Q2 		$9K Buy
+6
New +$9.58K ﹤0.01% 1721

Other funds holding SONM

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $737M AUM 158.15% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

ExodusPoint Capital Management's SONM Position: Q3 2020 in Review

ExodusPoint Capital Management sold out of DNA X Inc (SONM) in Q3 2020, closing a stake of 6 shares — an estimated $9K sold.

ExodusPoint Capital Management first reported a position in SONM in Q2 2020 and held it in 1 quarter. The position peaked at $9K in Q2 2020. 34 funds tracked by Wall St. Rank hold SONM as of Q3 2020.

  • ExodusPoint Capital Management reported no remaining DNA X Inc position as of Q3 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 6 DNA X Inc shares in Q3 2020, an estimated $9K.
  • ExodusPoint Capital Management first reported a position in DNA X Inc in Q2 2020 and held it in 1 quarter.
  • ExodusPoint Capital Management's DNA X Inc position peaked at $9K in Q2 2020.
  • 34 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2020.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.